학술논문

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Document Type
Article
Source
Clinical Pharmacology & Therapeutics; Jun2021, Vol. 109 Issue 6, p1417-1423, 7p
Subject
PROTON pump inhibitors
PHARMACOGENOMICS
CLARITHROMYCIN
DUODENAL ulcers
CYTOCHROME P-450
GASTROESOPHAGEAL reflux
HELICOBACTER diseases
Language
ISSN
00099236
Abstract
Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)